Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Nelson

Showing results (321-330 of 521) with videos related to

Pageof 53
Sort By:
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus TrialsHansi Zhang, Zhe He, Xing He, et al.
BMC Genomics|November 20, 2010
Identification and developmental expression of the full complement of Cytochrome P450 genes in ZebrafishJared V Goldstone, Andrew G McArthur, Akira Kubota, et al.
Critical Care (London, England)|June 20, 2006
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcomeAndrew F Shorr, Gordon R Bernard, Jean-Francois Dhainaut, et al.
Oncology Letters|December 4, 2012
Serum levels of soluble CD25 as a marker for hepatocellular carcinomaRoniel Cabrera, Asem I Fitian, Miguel Ararat, et al.
Hepatology (Baltimore, Md.)|March 3, 2010
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirinMoises Diago, Mitchell L Shiffman, Jean-Pierre Bronowicki, et al.
Clinical and Experimental Rheumatology|January 9, 2013
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapiesKhaled Sarsour, Jeffrey Greenberg, Joseph A Johnston, et al.
International Journal of Molecular Sciences|July 12, 2020
Comparative Analysis, Structural Insights, and Substrate/Drug Interaction of CYP128A1 in <i>Mycobacterium tuberculosis</i>Nokwanda Samantha Ngcobo, Zinhle Edith Chiliza, Wanping Chen, et al.
Journal of Viral Hepatitis|June 3, 2022
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trialDonna M Evon, Meichen Dong, Bryce B Reeve, et al.
Current Medical Research and Opinion|October 26, 2017
Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic controlCarlos I Alatorre, Byron J Hoogwerf, Mark A Deeg, et al.
International Journal of Fertility and Women'S Medicine|December 10, 2002
Effects of temperature on sperm motion characteristics and reactive oxygen speciesNavid Esfandiari, Ramadan A Saleh, Andrew P Blaut, et al.
Pageof 53

Showing results (321-330 of 521) with videos related to

Sort By:
Pageof 53
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus TrialsHansi Zhang, Zhe He, Xing He, et al.
BMC Genomics|November 20, 2010
Identification and developmental expression of the full complement of Cytochrome P450 genes in ZebrafishJared V Goldstone, Andrew G McArthur, Akira Kubota, et al.
Critical Care (London, England)|June 20, 2006
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcomeAndrew F Shorr, Gordon R Bernard, Jean-Francois Dhainaut, et al.
Oncology Letters|December 4, 2012
Serum levels of soluble CD25 as a marker for hepatocellular carcinomaRoniel Cabrera, Asem I Fitian, Miguel Ararat, et al.
Hepatology (Baltimore, Md.)|March 3, 2010
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirinMoises Diago, Mitchell L Shiffman, Jean-Pierre Bronowicki, et al.
Clinical and Experimental Rheumatology|January 9, 2013
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapiesKhaled Sarsour, Jeffrey Greenberg, Joseph A Johnston, et al.
International Journal of Molecular Sciences|July 12, 2020
Comparative Analysis, Structural Insights, and Substrate/Drug Interaction of CYP128A1 in <i>Mycobacterium tuberculosis</i>Nokwanda Samantha Ngcobo, Zinhle Edith Chiliza, Wanping Chen, et al.
Journal of Viral Hepatitis|June 3, 2022
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trialDonna M Evon, Meichen Dong, Bryce B Reeve, et al.
Current Medical Research and Opinion|October 26, 2017
Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic controlCarlos I Alatorre, Byron J Hoogwerf, Mark A Deeg, et al.
International Journal of Fertility and Women'S Medicine|December 10, 2002
Effects of temperature on sperm motion characteristics and reactive oxygen speciesNavid Esfandiari, Ramadan A Saleh, Andrew P Blaut, et al.
Pageof 53